Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (Asia Pacific)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (Asia Pacific)
Google plans to put datacentres in space to meet demand for AI
4/11/2025
NHS staff bearing brunt as ‘ugly’ racism of 70s and 80s returns, says Streeting
4/11/2025
The Guardian view on Rachel Reeves’s speech : gambling on a mirage of stability | Editorial
4/11/2025
The Guardian view on Europe’s housing crisis : time for the EU to get radical | Editorial
4/11/2025
Ben Jennings on Rachel Reeves’s plans for the autumn budget – cartoon
4/11/2025
De Niro to JLaw : should celebrities be expected to speak out against Trump ?
4/11/2025